
The scientific literature on transgender athletes does not say what either side of this fight wants it to say outright — it says something more unsettled, and that unsettled middle ground is precisely why a single sentence in a Seattle Times article about Washington’s trans-athlete ballot measure has drawn sustained criticism from scientists, journalists, and Caitlyn Jenner alike.
Key Points
- The Seattle Times stated flatly that “there is no serious scientific evidence” transgender girls or women hold an athletic advantage over cisgender competitors — a claim narrower than what the underlying research actually supports.
- Multiple peer-reviewed reviews, including a 2020 analysis by Hilton and Lundberg, find that strength and lean-mass advantages are reduced by hormone therapy but often persist in absolute terms for years.
- A widely cited U.S. military study found transgender women still ran 12% faster than cisgender women on a 1.5-mile test after two years of testosterone suppression.
- Earlier systematic reviews, including the 2017 Harper et al. paper the Seattle Times likely drew on, found no direct or consistent evidence of advantage — showing the field has genuinely shifted, not merely disagreed.
- The real fight is less about raw data than about which statistical frame — relative change versus absolute performance — should govern sport eligibility policy.
What the Seattle Times Actually Claimed, and Where It Came From
The disputed line appeared in a Seattle Times piece explaining why Washington voters approved a measure restricting transgender participation in girls’ school sports despite the state’s deep blue lean. The article asserted there is “no serious scientific evidence that trans girls or women are better athletes than cisgender girls or women”. That framing traces most directly to a 2017 systematic review published in Sports Medicine, which concluded there was “no direct or consistent research suggesting transgender female individuals… have an athletic advantage at any stage of their transition,” and noted that post-suppression running times were significantly slower than pre-transition times. That review was real, peer-reviewed, and influential in shaping early sport-governance policy.
The trouble is that science on this question did not stop in 2017. A 2020 review by Hilton and Lundberg, published in the same journal family, reached a more qualified conclusion: testosterone suppression reduces lean body mass, muscle area, and strength by only around 5% after twelve months of treatment, leaving “strength, skeletal- and muscle-mass derived advantages” largely intact. A separate systematic review in the British Journal of Sports Medicine found that while transgender women’s physiological markers declined during hormone therapy, their absolute values often remained above typical cisgender female ranges even after 36 months. These are not fringe papers; they sit in the same peer-reviewed tier as the 2017 review the Seattle Times cited, and they complicate — rather than refute — the newspaper’s framing.
The Military Study and Why 12% Became a Flashpoint
The most frequently invoked piece of counter-evidence is a study of transgender women in the U.S. Air Force, which tracked fitness-test performance before and after hormone therapy. Before treatment, the cohort outperformed female averages by roughly 31% on push-ups and finished the 1.5-mile run about 21% faster; after one year of suppression that running gap had narrowed to 9%, and after two years it still stood at 12%. Co-author Timothy Roberts told fact-checkers the advantage “continued to diminish the longer they were on testosterone blockers” — a genuine qualification, not a retraction. But a diminishing advantage that remains statistically measurable at the two-year mark is not the same thing as no advantage at all, and critics including Seattle talk-radio host Jason Rantz and investigative journalist Benjamin Ryan have cited exactly this study, alongside a 2025 paper reporting persistent advantages in strength, power, size, and aerobic capacity, to argue the newspaper overstated its case.
How Testosterone Suppression Actually Changes the Body
The mechanism explains why both camps can point to real data. Male puberty builds lean muscle mass, bone density, cardiac output, and lung capacity under the influence of testosterone; once that hormone is suppressed, the body does lose some of those gains, but skeletal structure, height, and certain cardiovascular adaptations are largely fixed and do not reverse. Hemoglobin and hematocrit — which govern oxygen-carrying capacity — normalize to female-typical levels within about four months of hormone therapy, which is why endurance advantages erode fastest. Strength and lean mass, by contrast, decline far more slowly and modestly, which is why reviews focused on those metrics tend to find more durable differences than reviews focused on hemoglobin or short-sprint speed. A claim that treats the sport-wide picture as settled in either direction is, by the mechanism alone, oversimplifying.
A History of Shifting Thresholds, Not a Single Verdict
Sport governance has never waited for a single definitive experiment before setting eligibility rules, and it is not about to start now. The International Olympic Committee’s 2003 Stockholm framework required surgical transition; by the 2010s it had shifted to a testosterone-based threshold, including the twelve-month suppression window that most of the cited research now uses as its benchmark. Each revision reflected an institutional judgment about where to draw a fairness line amid incomplete data, not a scientific consensus reached and then implemented. A 2025 preprint on physical fitness and body composition in transgender athletes catalogued the same structural problem that has dogged this field for two decades: limited long-term hormone data, underrepresentation of competitive transgender athletes in the samples, and inconsistent control for training history and the age at which hormone blockers began. Those gaps are why a newspaper, a review, and a retired Olympic decathlon champion can all cite “the science” and mean different studies.
Where That Leaves the Public Debate
Caitlyn Jenner’s on-camera rebuttal — that the NCAA and the IOC themselves “have proven” an advantage exists, bolstered by her own golf drive averaging roughly 280 yards against an LPGA average of 259.8 yards — is personal testimony, not a peer-reviewed rebuttal, but it captures the gut-level reaction many readers had to a flatly stated “no evidence” claim sitting atop a literature that is visibly more contested than that. The honest synthesis is this: the 2017 review the Seattle Times leaned on was accurate to its moment, but subsequent, equally credible research has found residual advantages that persist well past a year of treatment, particularly in absolute strength and short-distance speed. Readers encountering categorical claims on either side of this debate should treat them with the same skepticism they’d apply to any sweeping statement about a literature that researchers themselves describe as still evolving.
The sports that have blanket banned trans women their policies are based on the flawed assumption that transgender women retain inherent physical advantages and would therefore dominate women’s competitions.
The research and over 50 years of trans women competing in elite female…
— Kirsti Miller (@KirstiMiller30) November 16, 2026
The Policy Question Behind the Science Question
Even a perfectly settled body of research would not resolve the underlying policy dispute, because eligibility rules ultimately encode a value judgment about how much residual advantage a sport is willing to tolerate in the name of inclusion — a question no dataset can answer by itself. That is why the same studies get cited by state legislatures writing restrictive laws and by medical associations urging caution against blanket bans. The science clarifies magnitude and timeline; it does not, and cannot, dictate where a governing body should set its threshold. Expect this argument to keep resurfacing precisely because the research keeps producing partial, directional answers rather than a final one.
Sources:
facebook.com, bjsm.bmj.com, link.springer.com, seattletimes.com, pmc.ncbi.nlm.nih.gov, hal.science, foxnews.com, seattlered.com, cris.brighton.ac.uk





